You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
University College London researchers sequenced a woman who realized late in life that she could not feel pain, Gizmodo reports.
The addition of the Y chromosome detection will enable the firm to refine its already-approved MaternalFetalScreen T1 test to provide personalized risk assessment.
Funds raised will help accelerate commercialization of the firm's InVisionFirst-Lung liquid biopsy test and support development of the firm's platform for new indications
The partners will develop patient-specific assays based on ArcherDx's anchored multiplex PCR technology to track disease recurrence in lung cancer patients.
Researchers detected distinct antibiotic resistance patterns in untreated urban wastewater samples from northern and southern Europe.
With gut metagenomic sequences from two population cohorts, investigators identified associations between health traits and microbial structural variants.
The AP's Candace Choi writes that the diet and nutrition advice she received from two direct-to-consumer genetic testing firms was broad.
Retraction Watch speaks with an official from Montenegro about its newly adopted academic misconduct law.
In Genome Research this week: mutational signature linked to acrylamide exposure, computational platform for identifying viral integrations in cancer, and more.
Speakers at this year's ABRF meeting described how they used single-cell tools in combination with other single-cell approaches and other methods.
Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.
A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.
In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.